CAT No: CP04004
CAS No:190897-47-3
Synonyms/Alias:190897-47-3;(S)-3-((tert-Butoxycarbonyl)amino)-2-methylpropanoicacid;(S)-3-(Boc-amino)-2-methylpropionicacid;BOC-S-3-AMINOISOBUTYRICACID;(S)-Boc-beta2-Homoala-OH;(S)-3-TERT-BUTOXYCARBONYLAMINO-2-METHYL-PROPIONICACID;(S)-N-T-BUTYLOXYCARBONYL-3-AMINO-2-METHYLPROPIONICACID;BOC-S-AMPA-OH;(S)-Boc-b2-HomoAla-OH;(S)-Boc-|A2-Homoala-OH;40195_ALDRICH;SCHEMBL4740872;40195_FLUKA;CTK5J1661;MolPort-003-931-949;ZINC2389504;9922AA;ANW-63291;(S)-3-(N-Boc-Amino)isobutyricacid;AKOS015893066;AB17477;CB-3711;GS-0809;AJ-35594;AK-87761
Boc-S-3-Aminoisobutyric acid is a Boc-protected amino acid derivative designed for peptide and peptidomimetic synthesis workflows, featuring a side chain consistent with 3-aminoisobutyric acid substitution while the N-terminus is masked as a tert-butoxycarbonyl (Boc) carbamate. This protected format supports controlled coupling during protected amino acid assembly and is commonly selected when a specific residue identity and stereochemical integrity are required in downstream peptide construction. The Boc group provides a practical handle for stepwise synthesis and purification of peptide intermediates, making this building block useful for researchers developing modified peptides and pharmaceutical-grade intermediates.
1. Boc-Based Peptide Building
Boc-S-3-Aminoisobutyric acid is used as a protected amino acid building block for assembling peptides and peptidomimetics where the 3-aminoisobutyric acid residue identity is required at a defined position. Peptide synthesis teams in academic peptide chemistry groups and contract custom peptide manufacturing commonly rely on Boc-protected amino acid derivatives to generate well-defined peptide segments, particularly when iterative intermediate isolation and purification are part of the workflow. The Boc-protected amino functionality supports reliable incorporation into peptide chains, enabling the preparation of modified peptides used in structure-activity relationship studies and sequence optimization campaigns.
2. Peptidomimetic SAR Intermediates
Boc-S-3-Aminoisobutyric acid is frequently deployed in medicinal chemistry programs that build peptidomimetic scaffolds and analog libraries, where side-chain identity and backbone presentation strongly influence conformational preferences and physicochemical behavior. Small-molecule and peptide-drug discovery groups use this residue as an intermediate to introduce a defined amino acid-like unit into larger synthetic targets, supporting systematic SAR development through controlled variation of sequence context. Because the compound is already protected for synthesis, it fits cleanly into downstream intermediate-to-target coupling strategies used for generating candidate series and reference compounds for analytical characterization.
3. Pharmaceutical Intermediate Synthesis
Boc-S-3-Aminoisobutyric acid serves as a practical pharmaceutical intermediate for the preparation of higher-complexity, protected peptide fragments and related synthetic intermediates. Process development chemists and industrial chemical manufacturing teams use Boc-protected amino acid derivatives to manage reactivity during multistep assembly, especially when the synthetic route requires sequential functional group exposure and intermediate handling. This building block is therefore well aligned with workflows that prioritize controlled synthesis of defined, residue-specific intermediates for later conversion into final research materials or advanced synthetic targets.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.